|
1
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Witjes JA, Compérat E, Cowan NC, De Santis
M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG and Sherif A:
European Association of Urology: EAU guidelines on muscle-invasive
and metastatic bladder cancer: Summary of the 2013 guidelines. Eur
Urol. 65:778–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Wang L, Tang Y, Gong G, Liu L,
Chen M, Chen Z, Cui Y, Li C, Cheng X, et al: Maspin enhances
cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and
correlates with prognosis of muscle-invasive bladder cancer
patients receiving cisplatin based neoadjuvant chemotherapy. J Exp
Clin Cancer Res. 35:22016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Powles T, Eder JP, Fine GD, Braiteh FS,
Loriot Y, Cruz C, Bellmunt J, Burris HA, Petrylak DP, Teng SL, et
al: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in
metastatic bladder cancer. Nature. 515:558–562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alfred WJ, Lebret T, Compérat EM, Cowan
NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J,
Rouanne M, et al: Updated 2016 EAU guidelines on muscle-invasive
and metastatic bladder cancer. Eur Urol. 71:462–475. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohammed AA, El-Tanni H, El-Khatib HM,
Mirza AA, Mirza AA and Alturaifi TH: Urinary bladder cancer:
biomarkers and target therapy, new era for more attention. Oncol
Rev. 10:3202016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen T, Xie W, Xie L, Sun Y, Zhang Y, Shen
Z, Sha N, Xu H, Wu Z, Hu H and Wu C: Expression of long noncoding
RNA lncRNA-n336928 is correlated with tumor stage and grade and
overall survival in bladder cancer. Biochem Biophys Res Commun.
468:666–670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Necsulea A, Soumillon M, Warnefors M,
Liechti A, Daish T, Zeller U, Baker JC, Grützner F and Kaessmann H:
The evolution of lncRNA repertoires and expression patterns in
tetrapods. Nature. 505:635–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang M, Lu W, Huang Y, Shi J, Wu X, Zhang
X, Jiang R, Cai Z and Wu S: Downregulation of the long noncoding
RNA TUG1 inhibits the proliferation, migration, invasion and
promotes apoptosis of renal cell carcinoma. J Mol Histol.
47:421–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Q, Su M, Lu G and Wang J: The
complexity of bladder cancer: Long noncoding RNAs are on the stage.
Mol Cancer. 12:1012013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan J, Li X, Wu W, Xue M, Hou H, Zhai W
and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine
resistance through CREB modulating miR-196a-5p in bladder cancer
cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ying L, Huang Y, Chen H, Wang Y, Xia L,
Chen Y, Liu Y and Qiu F: Downregulated MEG3 activates autophagy and
increases cell proliferation in bladder cancer. Mol Biosyst.
9:407–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hua Q, Lv X, Gu X, Chen Y, Chu H, Du M,
Gong W, Wang M and Zhang Z: Genetic variants in lncRNA H19 are
associated with the risk of bladder cancer in a Chinese population.
Mutagenesis. 31:531–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Chen W, Yang C, Wu W, Wu S, Qin X
and Li X: Long non-coding RNA UCA1a(CUDR) promotes proliferation
and tumorigenesis of bladder cancer. Int J Oncol. 41:276–284.
2012.PubMed/NCBI
|
|
16
|
Zhan Y, Lin J, Liu Y, Chen M, Chen X,
Zhuang C, Liu L, Xu W, Chen Z, He A, et al: Up-regulation of long
non-coding RNA PANDAR is associated with poor prognosis and
promotes tumorigenesis in bladder cancer. J Exp Clin Cancer Res.
35:832016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhan Y, Li Y, Guan B, Chen X, Chen Z, He
A, He S, Gong Y, Peng D, Liu Y, et al: Increased expression of long
non-coding RNA CCEPR is associated with poor prognosis and promotes
tumorigenesis in urothelial bladder carcinoma. Oncotarget.
8:44326–44334. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayn MH, Hussain A, Mansour AM, Andrews
PE, Carpentier P, Castle E, Dasgupta P, Rimington P, Thomas R, Khan
S, et al: The learning curve of robot-assisted radical cystectomy:
Results from the International Robotic Cystectomy Consortium. Eur
Urol. 58:197–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Struhl K: Transcriptional noise and the
fidelity of initiation by RNA polymerase II. Nat Struct Mol Biol.
14:103–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta Chandra S and Tripathi Nandan Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harries LW: Long non-coding RNAs and human
disease. Biochem Soc Trans. 40:902–906. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou M, Zhao H, Wang Z, Cheng L, Yang L,
Shi H, Yang H and Sun J: Identification and validation of potential
prognostic lncRNA biomarkers for predicting survival in patients
with multiple myeloma. J Exp Clin Cancer Res. 34:1022015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Q, Su M, Lu G and Wang J: The
complexity of bladder cancer: Long noncoding RNAs are on the stage.
Mol Cancer. 12:1012013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen J, Miao Z, Xue B, Shan Y, Weng G and
Shen B: Long non-coding RNAs in urologic malignancies: Functional
roles and clinical translation. J Cancer. 28:1842–1855. 2016.
View Article : Google Scholar
|
|
28
|
Li LJ, Zhu JL, Bao WS, Chen DK, Huang WW
and Weng ZL: Long noncoding RNA GHET1 promotes the development of
bladder cancer. Int J Clin Exp Pathol. 7:7196–7205. 2014.PubMed/NCBI
|
|
29
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
30
|
Zhu YP, Bian XJ, Ye DW, Yao XD, Zhang SL,
Dai B, Zhang HL and Shen YJ: Long noncoding RNA expression
signatures of bladder cancer revealed by microarray. Oncol Lett.
7:1197–1202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao XL, Zhao ZH, Xu WC, Hou JQ and Du XY:
Increased expression of SPRY4-IT1 predicts poor prognosis and
promotes tumor growth and metastasis in bladder cancer. Int J Clin
Exp Pathol. 8:1954–1960. 2015.PubMed/NCBI
|
|
32
|
Yan TH, Lu SW, Huang YQ, Que GB, Chen JH,
Chen YP, Zhang HB, Liang XL and Jiang JH: Upregulation of the long
noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder
cancer. Tumour Biol. 35:10249–10257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
